213 related articles for article (PubMed ID: 27305771)
1. Synthesis and Characterization of Inhalable Flavonoid Nanoparticle for Lung Cancer Cell Targeting.
Lee WH; Loo CY; Ong HX; Traini D; Young PM; Rohanizadeh R
J Biomed Nanotechnol; 2016 Feb; 12(2):371-86. PubMed ID: 27305771
[TBL] [Abstract][Full Text] [Related]
2. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
[No Abstract] [Full Text] [Related]
3. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
5. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
Lee WH; Loo CY; Rohanizadeh R
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
[TBL] [Abstract][Full Text] [Related]
8. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells.
Hasanpoor Z; Mostafaie A; Nikokar I; Hassan ZM
Int J Biol Macromol; 2020 Sep; 159():137-153. PubMed ID: 32335119
[TBL] [Abstract][Full Text] [Related]
11. [Preparation, characterization and Calu-3 cellular uptake of three kinds of poly(b-benzyl-L-amino)block-poly(ethylene glycol) nanoparticles].
Zhou Y; Lu LN; Xin X; Huo DF; Wu HB; Qiu MF
Yao Xue Xue Bao; 2013 Apr; 48(4):560-5. PubMed ID: 23833946
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
13. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity.
Lee WH; Bebawy M; Loo CY; Luk F; Mason RS; Rohanizadeh R
J Biomed Nanotechnol; 2015 Jun; 11(6):1093-105. PubMed ID: 26353597
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874
[TBL] [Abstract][Full Text] [Related]
18. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy.
Sauraj ; Kumar SU; Kumar V; Priyadarshi R; Gopinath P; Negi YS
Carbohydr Polym; 2018 May; 188():252-259. PubMed ID: 29525163
[TBL] [Abstract][Full Text] [Related]
19. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
[TBL] [Abstract][Full Text] [Related]
20. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]